Fig. 5From: Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studiesCorrelations between change in UAS7 and change in MOS sleep disturbance: a ASTERIA I, b GLACIAL. UAS7 Weekly Urticaria Activity Score, MOS-Sleep Scale Medical Outcomes Study Sleep Scale, PRO patient-reported outcomesBack to article page